Theralase Technologies Inc. TLTFF
0.15 USD +0.01 (+9.27%)
Nov 3, 2026, 9:48 AM EST
0.1497 Day range 0.1497
0.10 52-week range 0.31
- YTD
- +24.75%
- 1 year
- +6.93%
- Market cap
- 46.48M
- EPS (ttm)
- -0.01
- YTD return
- +24.75%
- 1-year return
- +6.93%
- Volume
- 5.00K
- Avg volume
- 139.63K
- Open
- 0.1497
- Previous close
- 0.137
- Day's range
- 0.1497 – 0.1497
- 52-week range
- 0.10 – 0.31
2Y -0.0403 (-21.21%)
News
Theralase Provides Bladder Cancer Clinical Study Update 
Theralase(R) to Present at ThinkEquity Conference 
Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements 
Theralase(R) Releases Q2 2026 Financial Statements 
Theralase(R) Closes C$3.6 Million Brokered Financing 
Theralase(R) Announces $5 Million Brokered LIFE Offering 
Theralase(R) Grants Stock Options 
Theralase(R) Engages Global One Media to Expand Global Investor Awareness 
Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus 
Theralase(R) Lists Warrants on the TSXV
Your note
Sign in to keep a note on TLTFF — it syncs with the Stock Master app.